Cancer research
Research conducted by the University of Texas MD Anderson Cancer Center has shed light on the complex process of bone metastasis, revealing a key regulator in the development of this devastating cancer. According to study results published in Science Translational Medicine, acyl-coenzyme A (CoA) binding protein (ACBP) has been identified
Cancer research
A study published in the Journal of Nippon Medical School examined the clinical outcomes of triplet therapy in patients with metastatic castration-sensitive prostate cancer (mCSPC) at Nippon Medical School Hospital in Japan. The research aimed to evaluate the efficacy and safety of the treatment, which consisted of androgen deprivation therapy,
Cancer research
A recent report has highlighted a concerning decline in the uptake of a vaccine that could significantly increase the chances of avoiding one of the most preventable forms of cancer. The human papillomavirus (HPV) vaccine is typically offered to school pupils aged between 12 and 13 to combat the spread
Cancer research
Researchers at Beijing University of Chinese Medicine have made significant advancements in developing personalized cancer vaccines, targeting tumor-associated macrophages and enhancing antigen utilization efficiency. This innovative approach has shown promising results in eliciting systemic anti-tumor immunity and alleviating the immunosuppressive tumor microenvironment. Key Takeaways: * The study highlights the challenges in
Cancer research
MAIA Biotechnology, a clinical-stage biopharmaceutical company, has entered into a clinical master supply agreement with Roche to investigate the combination of its telomere-targeting agent ateganosine and Roche's checkpoint inhibitor atezolizumab for the treatment of hard-to-treat cancers. The partnership aims to strengthen MAIA's mission to find safe
Cancer research
Current study results on gastric cancer have been published, highlighting the impact of tertiary-lymphoid-structure-related genes on the clinical prognosis and tumor immune environment of patients with gastric cancer. The research involved analyzing The Cancer Genome Atlas data and identifying 23 differentially expressed genes associated with the tumor microenvironment. These findings
Cancer research
Researchers have made new findings in the field of oncology, specifically in the treatment of non-small cell lung cancer, by investigating the combination of telaglenastat and nivolumab. Telaglenastat, a glutaminase 1 inhibitor, targets the dysregulation in glutamine metabolism in cancer cells and the tumor microenvironment. A phase I/II trial
Cancer research
A new study published in the Journal of Investigative Medicine High Impact Case Reports has highlighted the exceptional long-term response of an African American man with mutated metastatic lung adenocarcinoma to immunotherapy treatment. The patient's response, which lasted over two years, has been attributed to his STK11/TP53
Cancer research
A recent study has shed new light on the benefits of consolidative chest radiotherapy after chemoimmunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC). The research, published in the journal Discover Oncology, analyzed data from the National Cancer Database for patients diagnosed with ES-SCLC between 2017 and 2020. The
Cancer research
The National Liver Cancer Screening Trial (TRACER) has selected Fujifilm's AFP-L3 and DCP in vitro diagnostic tests to evaluate their effectiveness in detecting liver cancer in patients with cirrhosis or chronic hepatitis B. This trial is a significant step towards developing more accurate and early-stage liver cancer detection
Cancer research
ClearNote Health has announced the initiation of a major clinical study to enhance early detection for pancreatic cancer, a disease responsible for over 455,000 deaths worldwide each year. The Surveillance of pAncreatic health aFter diabEtes Diagnosis (SAFE-D) study, sponsored by University Hospital Southampton NHS Foundation Trust, aims to identify
Cancer research
Cancer screening rates in the US-affiliated Pacific Islands (USAPI) are alarmingly low, highlighting a pressing need for culturally tailored and effective screening strategies. A recent study published in Cancer Epidemiology revealed that in the USAPI, only 20.6% of eligible adults were up-to-date with breast cancer screening, 38.6% with
